BFKB8488A (Roche/Genentech) BFKB8488A is a humanized monoclonal antibody that selectively agonizes the FGFR1/-Klotho complex, avoiding FGFR2 and FGFR3 activation
This dramatically extends plasma half-life from ~1015 minutes (native IGF-1) to 2030 hours (LR3 form), with a corresponding increase in bioavailability
Research shows that a 30-minute bout of moderate-intensity exercise can help you feel more awake and alert, 4
Le Roux CW, Steen O, Lucas KJ, Startseva E, Unseld A, Hennige AM
Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database
Some substitutes have also been linked to an elevated risk of heart disease and other conditions